Skip to content

Epidemiological investigation of Borna disease virus infection in patients with central nervous system infectious diseases in Chongqing

Epidemiological investigation of Borna disease virus infection in patients with central nervous system infectious diseases in Chongqing

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200067027
Enrollment
Unknown
Registered
2022-12-23
Start date
2023-01-01
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infectious diseases of the central nervous system

Interventions

Group of Infectious diseases of the central nervous system:none

Sponsors

Chongqing University Three Gorges Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
No minimum to 100 Years

Inclusion criteria

Inclusion criteria: Inclusion Criteria: According to the existing guidelines for the diagnosis and treatment of central nervous system infectious diseases, the following diseases were diagnosed by clinical department physicians. 1. Encephalitis; 2. Myelitis; 3. Encephalomyelitis; 4. Meningitis; 5. Meningitis; 6. Meningeal meningoencephalitis. All patients signed the informed consent form, and this study was approved by the Ethics Committee of Three Gorges Hospital Affiliated to Chongqing University.

Exclusion criteria

Exclusion criteria: 1. Exclude patients with a history of severe mental disorders such as schizophrenia, and exclude patients with a history of anorexia, bulimia, primary obsessive-compulsive disorder, ADHD, mental retardation, autism, Asperger's syndrome, tics, and Down syndrome; 2. To exclude patients with serious medical conditions, such as: heart, liver, kidney, thyroid-related diseases, asthma, malignant tumors, organic diseases of the brain or other organs, or patients with serious organic diseases or other life-threatening conditions; 3. Exclude patients with obvious intellectual disability and severe cognitive dysfunction; 4. Refusal to participate in the project.

Design outcomes

Primary

MeasureTime frame
BoDV-1 specific P40 antigen;

Countries

China

Contacts

Public ContactShengli Chen

Chongqing University Three Gorges Hospital

csl02201@sohu.com+86 13896226960

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026